Your browser doesn't support javascript.
loading
Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis.
Fischer, M Dominik; Patalano, Francesco; Naujoks, Christel; Banhazi, Judit; Bouchet, Christine; O'Brien, Paul; Kay, Christine; Green, Jane; Durham, Todd; Bradley, Helena; Williamson, Nicola; Barclay, Melissa; Sims, Joel; Audo, Isabelle.
Afiliação
  • Fischer MD; Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Patalano F; Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Naujoks C; Centre for Ophthalmology, University Hospital Tuebingen, Tuebingen, Germany.
  • Banhazi J; Novartis Pharma AG, Basel, Switzerland.
  • Bouchet C; Novartis Pharma AG, Basel, Switzerland.
  • O'Brien P; Novartis Pharma AG, Basel, Switzerland.
  • Kay C; Novartis Pharma AG, Basel, Switzerland.
  • Green J; Novartis Ireland Ltd, Dublin, Ireland.
  • Durham T; Vitreoretinal Associates, Gainesville, FL, USA.
  • Bradley H; Discipline of Genetics, Faculty of Medicine, Memorial University of Newfoundland, Craig L Dobbin Genetics Research Centre, St. John's, Canada.
  • Williamson N; Foundation Fighting Blindness, Columbia, MD, USA.
  • Barclay M; Adelphi Values Ltd, Bollington, Cheshire, UK. helena.bradley@adelphivalues.com.
  • Sims J; Adelphi Values Ltd, Bollington, Cheshire, UK.
  • Audo I; Adelphi Values Ltd, Bollington, Cheshire, UK.
Ophthalmol Ther ; 12(2): 1359-1386, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36847938
ABSTRACT

INTRODUCTION:

Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) are rare inherited retinal degenerative disorders. The Visual Symptom and Impact Outcomes patient-reported outcome (ViSIO-PRO) and observer-reported outcome (ViSIO-ObsRO) instruments were developed in this population to assess visual function symptoms and impacts on vision-dependent activities of daily living (ADL) and distal health-related quality of life (HRQoL). This study aimed to explore the psychometric properties of the ViSIO-PRO and ViSIO-ObsRO in RP/LCA.

METHODS:

The 49-item ViSIO-PRO and 27-item ViSIO-ObsRO instruments were completed by 83 adult and adolescent patients and 22 caregivers of child patients aged 3-11 years with RP/LCA, respectively, at baseline and 12-16-day follow-up. Concurrent measures were also administered at baseline. Psychometric analyses assessed item (question) properties, dimensionality, scoring, reliability, validity, and score interpretation.

RESULTS:

Item responses were mainly evenly distributed across the response scale, and inter-item correlations were mostly moderate to strong (> 0.30) at baseline within hypothesized domains. Item deletion was informed by item properties, qualitative data, and clinical input and supported retention of 35 ViSIO-PRO items and 25 ViSIO-ObsRO items. Confirmatory factor analysis in line with pre-hypothesized domains supported a four-factor model assessing visual function symptoms, mobility, vision-dependent ADL, and distal HRQoL. A bifactor model supported calculation of total scores and four domain scores. Internal consistency was high for domain and total scores (Cronbach's alpha > 0.70) and test-retest reliability for total scores was strong between baseline and 12-16-day follow-up (intraclass correlation coefficients 0.66-0.98). Convergent validity was supported by strong correlations in a logical pattern with concurrent measures. Mean baseline scores differed significantly between severity groups. Distribution-based methods provided initial insights to guide interpretation of scores.

CONCLUSIONS:

Findings supported item reduction and established scoring of the instruments. Evidence of reliability and validity as outcome measures in RP/LCA was also reported. Further research is ongoing to explore responsiveness of the ViSIO-PRO and ViSIO-ObsRO instruments and interpretation of change scores.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Idioma: En Revista: Ophthalmol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Idioma: En Revista: Ophthalmol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido